Individualized medicine is the tailoring of medical and psychiatric treatment to the individual characteristics of each patient. The approach relies on scientific breakthroughs in our understanding of how a person’s unique molecular and genetic profile makes them susceptible to certain diseases. This same research is increasing our ability to predict which medical treatments will be safe and effective for each patient, and which ones will not be.
Here at Yantra we use a combination of neurotransmitter and pharmacogenetic testing to ensure we are customizing treatment for each individual based on their profiles.
PGharmacogenetic testing is a non-invasive genetic test utilizing an oral swab to identify how a patient’s genetic profile may impact their response to certain medications. Two patients, with the same diagnosis and prescribed the same medication and dose, may exhibit significantly different clinical responses.
The information from the test provides the health care providers a faster and more effective path to optimal medication management.
Neurotransmitters are the brain chemicals that facilitate the transmission of signals from one neuron to the next across a synapse. Neurotransmitters work with receptors in the brain to influence and regulate a wide range of processes such as mental performance, emotions, pain response and energy levels. Imbalances in certain neurotransmitters are associated with most of the prevalent symptoms and conditions seen in psychiatry today.
The information from this test helps the provider choose a medication to fit your specific neurotransmitter profile.